Updated May 19, 2020 - Politics & Policy

Trump's physician explains hydroxychloroquine decision

President Trump during a roundtable at the White House on Monday. Photo: Doug Mills - Pool/Getty Images)

President Trump's physician said in a statement Monday it was decided that hydroxychloroquine could be beneficial to him after a White House staffer tested positive for the coronavirus.

Why it matters: Trump said earlier Monday that he's been taking the antimalarial drug and a zinc supplement for "about a week and a half" as a preventative measure against the virus. The FDA warned last month that the drug should only be taken in hospitals because of the risk of heart complications. Its effectiveness against COVID-19 is unproven.

  • The president and many White House staffers are being regularly tested for COVID-19. Multiple West Wing staff members have tested positive for the virus, but Trump and Vice President Mike Pence have declined to enter quarantine.
  • The White House physician wrote on Monday that Trump is "in good health and has remained symptom-free."

What they're saying: "After numerous discussions he and I had regarding the evidence for and against the use of hydroxychloroquine, we concluded the potential benefit from treatment outweighed the relative risks," physician Sean Conley said.

Read the letter:

Editor's note: This story has been updated to correct the spelling of Sean Conley's last name.

Go deeper

U.S. coronavirus updates

Data: The Center for Systems Science and Engineering at Johns Hopkins; Map: Andrew Witherspoon/Axios. This graphic includes "probable deaths" that New York City began reporting on April 14.

About 40.7 million Americans have filed for unemployment since the coronavirus pandemic began, including 2.1 million more claims filed from last week.

Why it matters: Even as states reopen their economies, Americans are still seeking relief. Revised data out Thursday also showed U.S. economy shrunk by an annualized 5% in the first quarter — worse than the initially estimate of 4.8%.

CDC: Coronavirus antibodies could give "short-term immunity," but more data is needed

CDC director Robert Redfield briefs reporters on April 8. Photo: Mandel Ngan/AFP via Getty Images

Coronavirus antibody tests are still relatively unreliable, and it's unclear if people who get the virus are immune to getting it again, the Centers for Disease Control and Prevention cautioned on Tuesday.

What they're saying: The agency explicitly warned against using antibody tests to determine whether someone should return to work or to group people within schools or prisons.

Coronavirus accelerates AI in health care

Illustration: Sarah Grillo/Axios

From predicting outbreaks to devising treatments, doctors are turning to AI in an effort to combat the COVID-19 pandemic.

Why it matters: While machine learning algorithms were already becoming a part of health care, COVID-19 is likely to accelerate their adoption. But lack of data and testing time could hinder their effectiveness — for this pandemic, at least.